RMFEX
Price
$64.49
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
VGICX
Price
$83.71
Change
+$0.73 (+0.88%)
Updated
Jul 31 closing price
Net Assets
7.08B
Interact to see
Advertisement

RMFEX vs VGICX

RMFEX vs VGICX Comparison Chart in %
View a ticker or compare two or three
VS
RMFEX vs. VGICX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VGICX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 118B vs. VGICX (7.09B). RMFEX pays higher dividends than VGICX: RMFEX (1.41) vs VGICX (0.67). RMFEX was incepted earlier than VGICX: RMFEX (24 years) vs VGICX (29 years). VGICX (1.49) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 30.00 vs. VGICX (22.00). RMFEX has a lower initial minimum investment than VGICX: RMFEX (250) vs VGICX (1000). VGICX annual gain was more profitable for investors over the last year : 19.09 vs. RMFEX (9.45). VGICX return over 5 years is better than : 50.68 vs. RMFEX (39.25).
RMFEXVGICXRMFEX / VGICX
Total Expense Ratio0.621.4443%
Annual Report Gross Expense Ratio0.621.4942%
Fund Existence24 years29 years-
Gain YTD9.69415.49563%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets118B7.09B1,665%
Annual Yield % from dividends1.410.67212%
Returns for 1 year9.4519.0950%
Returns for 3 years34.4242.6181%
Returns for 5 years39.2550.6877%
Returns for 10 years100.56129.4578%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMFAX17.660.12
+0.68%
Nationwide BNY Mellon Dyn US Core A
VIDMX11.220.05
+0.45%
Virtus KAR Developing Markets I
SCVNX43.200.01
+0.02%
Allspring Small Company Value Inst
ASCRX19.75-0.01
-0.05%
American Century Small Company R
FBIOX28.07-0.77
-2.67%
Fidelity Select Biotechnology